☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Tempo Therapeutics
Tempo Therapeutics Reports the First Patient Dosing in the MOSAIC Trial of TT101 for Tissue Repair in Skin Cancer Surgery
September 6, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.